Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0050 (11.11%)
At close: Nov 28, 2025
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $2.09 million as of November 28, 2025. Its market cap has decreased by -94.96% in one year.
Market Cap
2.09M
Enterprise Value
77.25K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.26
Stock Price
$0.05
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 2.09M, a decrease of -98.58%. That is a compound annual growth rate of -78.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 2.09M | -88.03% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 566.42M |
| Glass House Brands | 508.04M |
| American Oncology Network | 429.20M |
| CytoDyn | 416.43M |
| Northwest Biotherapeutics | 394.51M |
| Silence Therapeutics | 323.08M |
| Nika Pharmaceuticals | 259.96M |